Monday, December 1, 2008

New Phase-I Clinical Trial: IL-2 and sirolimus

This trial is open to people diagnosed between 3 months and 4 years ago, so it's not a classic "honeymoon only" study, but it is limited. Patients will be given two drugs over a three month period. The hope is to preserve some beta cells. This is a classic phase-I trial, looking only at safety in a small number of patients.

US Government Clinical Trials Record: (NCT00525889)
Immune Tolerance Network Trial Record: (ITN018AI)
Info for patients:
General info on Sirolimus:
General info on IL-2:

Estimated Enrollment: 10
Study Start Date: August 2007
Estimated Study Completion Date: January 2012
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)

This study is being done in Seattle Washington, and is sponsored by NIAID.


No comments: